Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Pharm Des. 2006;12(9):1129-45.

Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring.

Author information

1
University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 315 Cooke Hall, Buffalo, NY 14260, USA. slish@buffalo.edu

Abstract

The observed inter-individual variation in antiretroviral pharmacokinetics (PK) that results in a wide range of drug exposures from fixed-dose regimens has led to increasing interest in the clinical use of therapeutic drug monitoring (TDM) to individualize dosing of antiretroviral therapy (ART). The focus of this review is to provide an overview of literature available to support therapeutic drug monitoring among the current classes of antiretrovirals, suggest patient populations that may benefit from TDM and bring forth some of the limitations that may exist for widespread use of TDM in a traditional clinical setting.

PMID:
16515491
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center